West Pharmaceutical Services (WST) Stock Price
West Pharmaceutical Services Price
Over the last 19 years West Pharmaceutical Services grew revenue by 6.6% annually, reaching 3.07 B USD. Earnings per share have grown at 10.8% per year over the last 19 years. For West Pharmaceutical Services, the net margin of 16.1% is down versus 23.4% a few years ago. At today's price the dividend yield works out to roughly 0.23%. The payout ratio is around 13% of earnings. The dividend has grown at 6.8% per year over the past 19 years. The consensus 12-month price target for West Pharmaceutical Services is 400.00 USD, about 8.1% above where the stock trades today. Of 23 analysts, 21 rate the stock a buy — an overall Buy consensus.
West Pharmaceutical Services stock price
West Pharmaceutical Services business model & stock analysis
Frequently asked questions about West Pharmaceutical Services
The business model of West Pharmaceutical Services Inc. revolves around the manufacturing and distribution of innovative packaging and delivery solutions for the pharmaceutical and healthcare industries. West Pharmaceutical specializes in the development and production of advanced systems, such as drug delivery systems, injectable components, and analytical lab services. With a strong focus on quality, safety, and patient outcomes, West Pharmaceutical collaborates with pharmaceutical companies worldwide to provide customized packaging solutions that enhance the stability, efficacy, and convenience of drug delivery. By leveraging their expertise in materials science, engineering, and technology, West Pharmaceutical Services Inc. positions itself as a trusted partner in supporting the global healthcare industry.
West Pharmaceutical Services Inc is primarily active in the pharmaceutical and healthcare industries.
The main competitors of West Pharmaceutical Services Inc in the market are Becton, Dickinson and Company (BD), Catalent Inc, and Gerresheimer AG.
West Pharmaceutical Services Inc, founded in 1923, is a global leader in innovative solutions for injectable drug administration. With a rich history spanning nearly a century, the company has continuously evolved to meet the needs of the healthcare industry. West specializes in designing and manufacturing packaging and delivery systems for pharmaceuticals, such as vials, syringe components, and auto-injectors. Their cutting-edge technologies ensure drug containment, administration, and patient safety. Recognized for excellence in quality and reliability, West serves pharmaceutical, biotechnology, and generics companies worldwide. With a commitment to advancing healthcare, West Pharmaceutical Services Inc is at the forefront of enabling the safe and efficient delivery of life-saving medications.
West Pharmaceutical Services Inc has achieved several significant milestones. It has become a global leader in innovative solutions for injectable drug administration, serving pharmaceutical, biotechnology, and healthcare industries. The company has successfully expanded its global footprint, establishing manufacturing facilities and expanding operations in various regions. It has consistently focused on research and development, resulting in the introduction of cutting-edge technologies and advanced products. West Pharmaceutical Services Inc has also prioritized sustainability initiatives, promoting eco-friendly practices and reducing its environmental impact. Overall, the company's dedication to excellence, global expansion, technological advancements, and environmental consciousness have been key milestones in its success.
West Pharmaceutical Services Inc is primarily present in various countries and regions around the world. The company has a strong global presence and operates in multiple key markets. Some of the prominent countries and regions where West Pharmaceutical Services Inc has a significant presence include the United States, Europe, Asia-Pacific, and Latin America. Its commitment to delivering innovative solutions and high-quality products has helped establish a strong foothold in these markets. With its global reach, West Pharmaceutical Services Inc continues to expand its operations and serve customers across different regions.
West Pharmaceutical Services Inc represents a commitment to quality, innovation, and patient safety. As a global leader in pharmaceutical packaging and delivery systems, the company focuses on providing solutions that ensure the integrity and efficacy of drug products. With a corporate philosophy centered on collaboration, West strives to enable its customers' success by understanding their needs and delivering reliable, advanced technologies. By consistently putting patient well-being at the forefront, West aims to enhance the global healthcare landscape through its cutting-edge products and services.
Analysts currently set an average price target of 405.40 USD for the West Pharmaceutical Services stock (median: 400.00 USD), implying +9.6 % versus the latest price. The consensus is based on 23 analyst ratings.
23 analysts currently rate the West Pharmaceutical Services stock: 21 recommend buying, 2 holding and 0 selling. For 2026, analysts expect West Pharmaceutical Services to generate revenue of 3.37 B USD and earnings per share of 8.97 USD.
Converted at the current exchange rate, the West Pharmaceutical Services share trades at 330.55 EUR (369.98 USD).
The West Pharmaceutical Services share (WST) is listed on 6 stock exchanges, including: NYSE (WST), SIX (Zürich) (WPS.SW), XETRA (WPS.DE), Frankfurt (WPS.F), München (WPS.MU), Düsseldorf (WPS.DU).
West Pharmaceutical Services Inc. is a leading provider of innovative packaging and delivery systems for the pharmaceutical, biotechnology, and medical industries. The company was founded in 1923 and is headquartered in Exton, Pennsylvania, USA. The business model of West Pharmaceutical Services Inc. is based on three main divisions: Primary Packaging, Drug Delivery Systems, and Healthcare Analytics. In each of these divisions, the company offers various products and services to meet the needs of its customers. Primary Packaging In the Primary Packaging division, West Pharmaceutical Services offers various products used for the packaging of drugs. These include stoppers, vials, caps, closures, and various other components. West Pharmaceutical Services specializes in innovative packaging solutions that help increase the safety and efficacy of medications. This includes special coatings that enhance the barrier properties of the packaging and reduce the ingress of oxygen and moisture. Drug Delivery Systems The Drug Delivery Systems division includes a wide range of products used for the administration of medications. These include syringes, pens, auto-injectors, nasal sprays, powder inhalers, and various other systems. West Pharmaceutical Services develops innovative solutions that contribute to the safe and uncomplicated administration of medications. The focus is on improving patient safety. Healthcare Analytics In the Healthcare Analytics division, West Pharmaceutical Services uses modern technologies to collect and analyze health data. The aim is to fill information gaps and enable better decision-making in healthcare. The data analysis and visualization provided by West Pharmaceutical Services help healthcare providers identify trends, make predictions, and improve treatment outcomes. Summary West Pharmaceutical Services offers innovative packaging and delivery systems for the pharmaceutical, biotechnology, and medical industries. It serves three main divisions: Primary Packaging, Drug Delivery Systems, and Healthcare Analytics. The company strives to improve the safety and efficacy of medications and enhance patient safety. Through the analysis of health data, the company contributes to making the healthcare system more efficient and cost-effective.
The expected revenue of West Pharmaceutical Services is 3.37 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of West Pharmaceutical Services is 652.12 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of West Pharmaceutical Services is currently 41.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the West Pharmaceutical Services stock.
The price-to-sales ratio (P/S) of West Pharmaceutical Services is currently 7.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the West Pharmaceutical Services stock.
The Eulerpool Quality Score for West Pharmaceutical Services is 6/10.
The ISIN of West Pharmaceutical Services is US9553061055. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of West Pharmaceutical Services is 864330. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of West Pharmaceutical Services is WST. The ticker symbol is used to trade West Pharmaceutical Services shares on the stock exchange.
West Pharmaceutical Services stock
West Pharmaceutical Services Peer Group
West Pharmaceutical Services Ticker
West Pharmaceutical Services FIGI
All fundamentals and in-depth analysis of West Pharmaceutical Services
Our stock analysis for West Pharmaceutical Services stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of West Pharmaceutical Services. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.